Jessica L. Bazin, MBChB, MSC, MRCP, FRCPath1,2*, Yasser Abou Mourad, MD, FRCPC, FACP1,2, Donna L. Forrest, MD, FRCPC1,2, Kevin A Hay, MD, MSc, FRCPC2,3,4,5, Florian Kuchenbauer, MD PhD1,2,4, Stephen H. Nantel, MD, FRCPC1,2, Sujaatha Narayanan, MBBS, MRCP, MRCPath1,2*, Thomas J. Nevill, MD, FRCPC1,2, Maryse Power, MB, FRCPI, FRCPath1,2, Judith A Rodrigo, MD, FRCPC1,2*, Claudie Roy, MD, FRCPC1,2*, David Sanford, MD1,2, Kevin Song, MD, FRCPC1,2, Ryan J. Stubbins, MD, MSc, FRCPC1,2, Heather J. Sutherland, MD, PhD, FRCPC1,2, Cynthia L. Toze, MD, FRCPC, MSc1,2*, Jennifer White, MD, MSc, FRCPC1,2* and Shanee Chung, MBChB, FRACP, FRCPA1,2
1The Leukemia/Bone Marrow Transplant Program of British Columbia, British Columbia Cancer Agency, Vancouver, BC, Canada
2Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada
3The Leukemia/Bone Marrow Transplant Program of British Columbia, Vancouver General Hospital, Vancouver, BC, Canada
4Terry Fox Laboratory, British Columbia Cancer Research Institute, Vancouver, BC, Canada
5Clinical Cell Therapy Laboratory, British Columbia Cancer Research Institute, Vancouver, BC, Canada